These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6977217)

  • 1. Immunogenetic aspects of the relationship between HLA-DR and the MB and MT system.
    Duquesnoy RJ
    Transplant Proc; 1981 Dec; 13(4):1804-7. PubMed ID: 6977217
    [No Abstract]   [Full Text] [Related]  

  • 2. Immediate rejection of a HLA-A, B compatible, HLA-DR incompatible kidney with a positive donor-recipient B-cell crossmatch.
    Berg B; Möller E
    Scand J Urol Nephrol Suppl; 1980; 54():36. PubMed ID: 7013039
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenetic analysis of the HLA-D region: serological and cellular detection of the MB system.
    Duquesnoy RJ; Zeevi A; Marrari M; Halim K
    Clin Immunol Immunopathol; 1982 May; 23(2):254-68. PubMed ID: 6179667
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA-DR typing and B cell cross-match tests in cadaveric renal transplantation.
    Albrechtsen D; Flatmark A; Halvorsen S; Jervell J; Solheim BG; Thorsby E
    Scand J Urol Nephrol Suppl; 1980; 54():25-8. PubMed ID: 7013036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated reading of Propidium Iodide lymphocytotoxicity tests for HLA-DR, MB, MT typing.
    Naipal AM; D'Amaro J; Bruning JW; van Leeuwen A; van Rood JJ
    Tissue Antigens; 1984 Nov; 24(5):302-6. PubMed ID: 6597977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-HLA-DR antibodies in the sera of multigravidae in labor].
    Cascino I; Mazzilli MC; Lulli P; Trabace S; Rosso M
    Riv Emoter Immunoematol; 1980; 27(3-4):151-5. PubMed ID: 6978508
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
    Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
    Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
    [No Abstract]   [Full Text] [Related]  

  • 8. Simulation study of kidney allocation to recipients with a zero mismatch for HLA-DRB1.
    Ichikawa Y; Hashimoto M; Hanafusa T; Kyo M; Kinoshita T; Yamasaki M; Ihara H; Fukunishi T; Nagano S
    Transplantation; 1994 Jul; 58(1):120-1. PubMed ID: 8036702
    [No Abstract]   [Full Text] [Related]  

  • 9. A method to facilitate the reading of up to 60 samples of monoclonal antibody-fluorescence stained cells using Medicell HLA-DR plates.
    Sensi M; Pozzilli P; Di Mario U
    J Clin Lab Immunol; 1984 Feb; 13(2):101-2. PubMed ID: 6374153
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term kidney graft outcome based on HLA-DRB1 matching.
    Nojima M; Ichikawa Y; Ihara H; Ishibashi MO; Ohshima S; Ikoma F
    Transplant Proc; 1994 Aug; 26(4):1884-6. PubMed ID: 7915054
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenetic and clinical findings in idiopathic pulmonary fibrosis. Association with the B-cell alloantigen HLA-DR2.
    Libby DM; Gibofsky A; Fotino M; Waters SJ; Smith JP
    Am Rev Respir Dis; 1983 May; 127(5):618-22. PubMed ID: 6405666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of HLA DR in renal transplantation.
    Fotino M; Suthanthiran M
    N Y State J Med; 1982 Mar; 82(3):327-32. PubMed ID: 7045739
    [No Abstract]   [Full Text] [Related]  

  • 13. Further study of the "tail portion" of antigen MT-2--an analysis of "Se-11".
    Sekiguchi S; Takata H; Konoeda Y; Ono C; Iri H
    Transplant Proc; 1981 Dec; 13(4):1991-5. PubMed ID: 6949391
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warm B-cell antibodies and DRw matching: their influence on transplant outcome at a single center.
    Coxe-Gilliland R; Cross DE
    Transplant Proc; 1981 Mar; 13(1 Pt 2):945-8. PubMed ID: 7022967
    [No Abstract]   [Full Text] [Related]  

  • 16. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
    Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR matching and B-cell crossmatching in renal transplantation.
    Ting A; Williams KA; Morris PJ
    Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.
    Würflein D; Dechant M; Stockmeyer B; Tutt AL; Hu P; Repp R; Kalden JR; van de Winkel JG; Epstein AL; Valerius T; Glennie M; Gramatzki M
    Cancer Res; 1998 Jul; 58(14):3051-8. PubMed ID: 9679970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative analysis of serologic typing and HLA-II typing by micro-PCR-SSP].
    Wu DL; Ling HX; Ding H; Zhang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):247-9. PubMed ID: 12390779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trial of HLA-A, B, versus HLA-DR matching in cadaveric renal transplantation.
    d'Apice AJ; Sheil AG; Tait BD; Bashir HV
    Transplant Proc; 1981 Mar; 13(1 Pt 2):938-41. PubMed ID: 7022965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.